BR112013001691A2 - particulados de metal geradores de corrente de corrosão e uso dos mesmos - Google Patents

particulados de metal geradores de corrente de corrosão e uso dos mesmos

Info

Publication number
BR112013001691A2
BR112013001691A2 BR112013001691A BR112013001691A BR112013001691A2 BR 112013001691 A2 BR112013001691 A2 BR 112013001691A2 BR 112013001691 A BR112013001691 A BR 112013001691A BR 112013001691 A BR112013001691 A BR 112013001691A BR 112013001691 A2 BR112013001691 A2 BR 112013001691A2
Authority
BR
Brazil
Prior art keywords
corrosion current
metal particles
current generating
generating metal
metal particulates
Prior art date
Application number
BR112013001691A
Other languages
English (en)
Inventor
Brooks Story
Chunlin Yang
James E Hauschild
Jeannette Chantalat
Jeffrey C Geesin
Jue-Chen Liu
Julia Hwang
Michael D Southall
Wei Kong
William R Parrish
Ying Sun
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BR112013001691A2 publication Critical patent/BR112013001691A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

particulados de metal geradores de corrente de corrosão e uso dos mesmos. a presente invenção refere-se a particulados de metal capazes de gerar baixos níveis de corrente de corrosão benéficos para usos farmacêuticos, cosméticos e outros usos médicos que são apresentados.
BR112013001691A 2010-07-23 2011-07-20 particulados de metal geradores de corrente de corrosão e uso dos mesmos BR112013001691A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36714510P 2010-07-23 2010-07-23
PCT/US2011/044646 WO2012012509A1 (en) 2010-07-23 2011-07-20 Corrosion current-generating metal particulates and use thereof

Publications (1)

Publication Number Publication Date
BR112013001691A2 true BR112013001691A2 (pt) 2016-05-24

Family

ID=44545892

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013001691A BR112013001691A2 (pt) 2010-07-23 2011-07-20 particulados de metal geradores de corrente de corrosão e uso dos mesmos

Country Status (4)

Country Link
US (1) US20120021014A1 (pt)
CN (1) CN103025335A (pt)
BR (1) BR112013001691A2 (pt)
WO (1) WO2012012509A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
MX2010003506A (es) * 2007-09-28 2010-04-21 Johnson & Johnson Consumer Particulas generadoras de electricidad y sus usos.
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
KR20110091461A (ko) * 2010-02-05 2011-08-11 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 갈바니 미립자를 포함하는 립 조성물
EP2542209A1 (en) * 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition
US8735001B2 (en) 2011-04-08 2014-05-27 Empire Technology Development Llc Gel formed battery
WO2012138354A1 (en) 2011-04-08 2012-10-11 Empire Technology Development Llc Moisture activated battery
US8828581B2 (en) 2011-04-08 2014-09-09 Empire Technology Development Llc Liquid battery formed from encapsulated components
US8744593B2 (en) 2011-04-08 2014-06-03 Empire Technology Development Llc Gel formed battery
BR112014019167A8 (pt) * 2012-02-29 2017-07-11 Avon Prod Inc Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-los
JP6096021B2 (ja) * 2013-03-22 2017-03-15 ファイテン株式会社 顎関節症用外用剤
KR20160056879A (ko) 2013-07-29 2016-05-20 쿠랄 코포레이션 반-전지를 통한 치료용 전자 및 이온 전달
CN103656717B (zh) * 2013-12-24 2016-05-04 北京绿伞化学股份有限公司 一种基于植物提取液为主的鞋袜除臭剂及其制备方法
US9474699B2 (en) 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
US9468606B2 (en) 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
US9795545B2 (en) 2014-06-16 2017-10-24 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a color cosmetic
US20150359742A1 (en) 2014-06-17 2015-12-17 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder
CN107413287A (zh) * 2017-08-15 2017-12-01 泰州希斯曼金属制品有限公司 在生物介质中用杀菌金属的纳米级对象的电化学处理方法
US11859080B2 (en) 2018-02-22 2024-01-02 Yeda Research And Development Co. Ltd. Hydroxyapatite based composites and films thereof
CN112457509B (zh) * 2020-11-25 2023-05-19 江苏省农业科学院 一种用于包装食品的抑菌膜
US11918875B2 (en) * 2021-01-07 2024-03-05 FSCFP Corporation Structures for sport fencing

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981747A (en) * 1971-08-03 1976-09-21 Societe Anonyme Automobiles Citroen Process for producing electric current by the electrochemical oxidation of an active anodic metal, especially zinc
ATE177939T1 (de) 1987-10-22 1999-04-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
DE69132363T2 (de) 1990-04-26 2001-03-29 Procter & Gamble Chelat-zubereitung, die alpha-diamin-verbindungen enthalten
AU662101B2 (en) 1990-04-26 1995-08-24 Procter & Gamble Company, The Chelator compositions comprising oxime compounds
DE19520312B4 (de) 1995-06-02 2004-09-16 Eckart-Werke Standard-Bronzepulver-Werke Carl Eckart Gmbh & Co. Oxidierte farbige Aluminiumpigmente, Verfahren zu deren Herstellung sowie deren Verwendung
DE19616287C5 (de) 1996-04-24 2013-11-14 Eckart Gmbh Verfahren zur Herstellung einer Perlglanzpigment-Zubereitung
DE19820112A1 (de) 1998-05-06 1999-11-11 Eckart Standard Bronzepulver Mit reaktiven Orientierungshilfsmitteln beschichtete Effektpigmente
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
DE102004005366A1 (de) 2004-02-03 2005-08-18 Eckart Gmbh & Co.Kg Kosmetisches Präparat enthaltend ein Metallpigment
US7413599B2 (en) 2004-08-26 2008-08-19 Eckart Gmbh & Co. Kg Coated pearlescent pigments with SiO2 and cerium oxide
AU2005308452A1 (en) 2004-11-26 2006-06-01 Stentomics, Inc. Chelating and binding chemicals to a medical implant
CN101257860B (zh) 2005-04-05 2015-10-21 万能医药公司 可降解的植入式医疗装置
US20070270942A1 (en) 2006-05-19 2007-11-22 Medtronic Vascular, Inc. Galvanic Corrosion Methods and Devices for Fixation of Stent Grafts
MX2010003506A (es) * 2007-09-28 2010-04-21 Johnson & Johnson Consumer Particulas generadoras de electricidad y sus usos.
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
US20100249927A1 (en) * 2009-03-27 2010-09-30 Chunlin Yang Medical devices with galvanic particulates

Also Published As

Publication number Publication date
US20120021014A1 (en) 2012-01-26
CN103025335A (zh) 2013-04-03
WO2012012509A1 (en) 2012-01-26

Similar Documents

Publication Publication Date Title
BR112013001691A2 (pt) particulados de metal geradores de corrente de corrosão e uso dos mesmos
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
BR112015000561A2 (pt) inibidores de irak e usos dos mesmos
BR112015011756A2 (pt) inibidores da glutamase e métodos de uso
BR112013027500A2 (pt) liberação controlada de imunossupressores de nanotransportadores sintéticos
BRPI1106572B8 (pt) Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
BR112013013167A8 (pt) inibidores de bromodomínio e usos dos mesmos
BR112013010834A2 (pt) polipeptídeos fator ix modificados e usos dos mesmos
BR112012024963A2 (pt) organossilicones
BR112015015898A8 (pt) composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
UY33504A (es) N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida deuterada, sales y usos de la misma
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
MX2016008448A (es) Conjugados de var2csa-farmaco.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112013028449A2 (pt) composições compreendendo partículas de hidrogel
BR112015006731A2 (pt) combinações e usos das mesmas
BR112014011254A2 (pt) 2-tiopirimidinonas
BR112013005855A2 (pt) heteroarilas fundidas e seus usos
CO7350653A2 (es) Retinoides y uso de los mismos
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
BR112015013675A2 (pt) composições compreendendo vortioxetina e donepezil
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
EA201590708A1 (ru) Модифицированные производные гиалуроновой кислоты и их применение
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired